510(k) Report

510(k) · Cleared

Cleared

HALO

K200873510(k) TraditionalCleared Nov 20, 2020233-day reviewClass II21 CFR 892.2080

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nico-Lab B.V. · QAS Radiological Computer-Assisted Triage And Notification Software

Cleared on Nov 20, 2020 as substantially equivalent to DEN170073 (Viz.Al, Inc., 2018) after a 233-day review. Its family tree reaches back 1 generation to 2018. 1 later device descends from it.

Decided
Nov 20, 2020
Review
233 days
Class
Class II
Product code
QAS
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN170073 (2018). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2021: 1 descendant clearedDEN170073 · ContaCT · Viz.Al, Inc. · 2018201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant DEN170073 · ContaCT · Viz.Al, Inc. · 20180
  1. Root · 1 generation backDEN170073 ContaCTViz.Al, Inc. · 2018
  2. This deviceK200873 HALONico-Lab B.V. · 2020
  3. Descendant · cites it directly · 0 of its ownK211788 HALONicolab B.V. · 2021

Most influential descendants

Showing 1 of 1 · See all
  • K211788HALONicolab B.V. · 2021 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN170073ContaCTViz.Al, Inc.2018—
0 (this device)K200873HALONico-Lab B.V.2020—
+1K211788HALONicolab B.V.2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
FIG. 1 — Lineage of K200873, 2018–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QAS device

  1. #1 K203508 BriefCasescore 25.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN170073ContaCT
Summary page 4
…uct Code: QAS Primary Predicate Trade Name: ContaCT Device: Manufacturer: Viz.Al, Inc. DeNovo Clearance: DEN170073 Classification Name: Radiological Computer-Assissted Triage and…
Viz.Al, Inc.2018—

Also cleared against DEN170073: 9 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K211788HALONicolab B.V.20210

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K211788 (Nicolab B.V., 2021) has gone furthest, with 0 descendants of its own.
  • 9 other devices also cite its predicate DEN170073.

How does its category compare?

All QAS devices

QAS Radiological Computer-Assisted Triage And Notification Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · QAS

15in 2025

2018: 32019: 52020: 122021: 52022: 152023: 112024: 122025: 152026 (partial year): 11
2007high 15 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QAS

101in 2025

2019: 111 days median2020: 112 days median2021: 86 days median2022: 116 days median2023: 98 days median2024: 136 days median2025: 101 days median2026 (partial year): 104 days median
2007high 136 (2024) · low 86 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QAS

No recall names QAS since 2007.

Adverse event reports per year · QAS

No MAUDE report names QAS since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20183—00
2019511100
20201211200
202158600
20221511600
2023119800
20241213600
20251510100
2026111040—

What is it indicated for?

HALO is a notification only cloud-based image processing software application using artificial intelligence algorithms to analyze patient imaging data in parallel to the standard of care imaging interpretation. Its intended use is to identify suggestive imaging patterns of a pre-specified clinical condition and to directly notify an appropriate medical specialist. HALO’s indication is to facilitate the evaluation of the brain vasculature on patients…

Read the full statement (200 words)

HALO is a notification only cloud-based image processing software application using artificial intelligence algorithms to analyze patient imaging data in parallel to the standard of care imaging interpretation. Its intended use is to identify suggestive imaging patterns of a pre-specified clinical condition and to directly notify an appropriate medical specialist.

HALO’s indication is to facilitate the evaluation of the brain vasculature on patients suspected of stroke by processing and analyzing contrast enhanced CT angiograms of the brain acquired in an acute setting. After completion of the data analysis, HALO sends a notification if a pattern suggestive for a suspected intracranial Large Vessel Occlusion (LVO) of the anterior circulation (ICA, M1 or M2) has been identified in an image.

The intended users of HALO are defined as appropriate medical specialists or a team of specialists that are involved in the diagnosis and care of stroke patients at emergency departments or other department where stroke patients are administered. They include physicians such as neurologists, radiologists, and/or other emergency department physicians.

HALO’s output should not be used for primary diagnosis or clinical decisions; the final diagnosis is always decided upon by the medical specialist. HALO is indicated for CT scanners from GE Healthcare.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K200873: HALO.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K200873

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026